Aftermarket Performance of Health Care and Biopharmaceutical IPOs: Evidence From ASEAN Countries

Inquiry - United States
doi 10.1177/0046958017727105
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

SAGE Publications